Pence’s Obamacare stance mirrors Hoosiers’ views
A new survey shows Hoosiers don’t like the Affordable Care Act, most would like to see it repealed, and by a nearly 2-to-1 margin, they support Pence’s handling of the question of expanding Medicaid.
Life Science & Biotech
Articles
J&J to pay $2.5B to settle hip replacement suits
The agreement is one of the largest ever for the medical device industry. It resolves an estimated 8,000 cases of patients who had to have the company’s metal ball-and-socket hip implant removed or replaced. The implants were made by J&J’s Indiana-based DePuy unit.
Health care has priced itself out of its own market
It’s no secret the growth of the U.S. economy slowed in the 2000s after the go-go decade preceding it. But the U.S. health care system—hospitals, doctors, drug companies, device makers and health insurers—apparently didn’t get that memo.
Obama’s telling the same kind of fib he did before
The Affordable Care Act was designed to restructure the individual insurance market into a true insurance risk pool. President Obama should stop pretending those changes won’t affect everyone in the individual market, whether they want it to or not.
MCCANN: Energy research evolving to meet massive demands
The days of lone-wolf researchers shouting ‘Eureka’ are over.
With Obamacare, insurers will still find ways to avoid risk
Obamacare put an end to health insurers’ worst methods for avoiding risk. But that doesn’t mean insurers have ended their risk-shifting ways. Not at all.
The bill for Hoosiers’ excess health care spending: About $5 billion per year
Hoosiers’ poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
Sale may extricate Harlan Labs from its debt problems
San Francisco-based Genstar Capital is exploring selling the 2,600-employee company in the wake of failing early this year to renegotiate the company’s massive debt load.
The frightening future that’s haunting hospitals
Why are Indiana’s hospitals cutting jobs. Because they’re spooked about cuts to Medicare payments. They should be.
Purdue makes big push into state’s pharma industry
With a $60 million-plus investment, the university aims to take molecules from discovery to clinical trials.
Think your coverage is unaffordable? Watch out for this Obamacare pitfall
Obamacare’s exchanges are requiring working Americans to grasp minute details of their employers’ health plans in order to avoid a nasty surprise from the IRS.
DowAgrosciences cultivates sales record, but profit withers
Despite a boost in third-quarter revenue due to crop-protection products, profit for the local unit of Dow Chemical tumbled more than 71 percent.
State medical institute snares $30M grant from feds
A consortium of Indiana University, Purdue University and University of Notre Dame can operate for another five years with the grant funds.
Is lack of competition hiking Indiana exchange premiums?
Only four health insurers are offering policies in the Obamacare exchange in Indiana, whereas 17 have withdrawn from the market since 2010.
Republicans making same old mistake on health reform
Rather than railing incessantly against Obamacare, Republicans would do themselves and the country a favor if they finally agreed on a common alternative for fixing the health care system.
Analysts: Investors wrong to dump Endocyte
Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.
Finding where the money is in health care
More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.
Shift from information scarcity to abundance will transform health care
With payment reform and new technology, it’s plausible that health care will shift from being a bricks and mortar business to an information business–bringing us higher quality and lower costs. That’s exciting.
Lilly scientists stole $55 million in trade secrets, indictment alleges
Three former employees of Eli Lilly and Co. allegedly transferred trade secrets that Lilly values at more than $55 million to a competing Chinese drug company, according to an indictment unsealed Tuesday in federal court.
Dow Agro wins latest patent case involving Enlist product
The suit, filed in January 2012 by South African-based Bayer CropScience SA, charged that Dow Agro’s Enlist E3 soybean seed infringed one of its patents.